BlackRock Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.32M | Sell |
346,511
-6,444
| -2% | -$24.5K | ﹤0.01% | 1988 |
|
|
2016
Q3 | $3.16M | Buy |
352,955
+17,891
| +5% | +$160K | ﹤0.01% | 1331 |
|
|
2016
Q2 | $2.36M | Buy |
335,064
+13,766
| +4% | +$96.9K | ﹤0.01% | 1452 |
|
|
2016
Q1 | $2.73M | Buy |
321,298
+17,397
| +6% | +$148K | ﹤0.01% | 1351 |
|
|
2015
Q4 | $3.99M | Sell |
303,901
-32,880
| -10% | -$432K | ﹤0.01% | 1168 |
|
|
2015
Q3 | $1.23M | Sell |
336,781
-121,728
| -27% | -$445K | ﹤0.01% | 1749 |
|
|
2015
Q2 | $2.64M | Sell |
458,509
-92,511
| -17% | -$533K | ﹤0.01% | 1405 |
|
|
2015
Q1 | $3.22M | Sell |
551,020
-94,691
| -15% | -$553K | ﹤0.01% | 1279 |
|
|
2014
Q4 | $5.06M | Buy |
+645,711
| New | +$5.06M | ﹤0.01% | 1120 |
|
|
2013
Q4 | – | Sell |
-13,520
| Closed | -$75K | – | 2728 |
|
|
2013
Q3 | $75K | Buy |
+13,520
| New | +$75K | ﹤0.01% | 2635 |
|